BPG is committed to discovery and dissemination of knowledge
Featured Articles
6/15/2020 8:46:08 AM | Browse: 874 | Download: 1764
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 53585
Country United States
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Immune checkpoint inhibitors induced colitis, stay vigilant: A case report
Manuscript Source Invited Manuscript
All Author List Suha Abu khalaf, Abdulmajeed Albarrak, Mohamad Yousef and Veysel Tahan
Funding Agency and Grant Number
Corresponding Author Suha Abu khalaf, MD, Doctor, Doctor, Department of Internal Medicine, University of Missouri, 1 Hospital Dr, Columbia, MO 65212, United States. abukhalafs@health.missouri.edu
Key Words Immunotherapy; Colitis; Melanoma; Case report; Ipilimumab; Hepatitis
Core Tip Immunotherapy is one of the novel treatments of this century, though it can cause many predicted and unpredicted immune-related side effects. This is a rare case of immunotherapy induced colitis in an otherwise healthy male who was recently diagnosed with melanoma and was started on appropriate immunotherapy treatment. Clinicians should keep in mind the possible immune side effects of immune checkpoint inhibitors as they can develop at any stage, which will help physicians in stopping these medications earlier and avoiding further serious harm.
Publish Date 2020-06-15 08:19
Citation Abu Khalaf S, Albarrak A, Yousef M, Tahan V. Immune checkpoint inhibitors induced colitis, stay vigilant: A case report. World J Gastrointest Oncol 2020; 12(6): 699-704
URL https://www.wjgnet.com/1948-5204/full/v12/i6/699.htm
DOI https://dx.doi.org/10.4251/wjgo.v12.i6.699
Full Article (PDF) WJGO-12-699.pdf
Full Article (Word) WJGO-12-699.docx